Shen is a breast cancer oncologist at Memorial Sloan Kettering Cancer Center (MSK) who studies the relationship between obesity, metabolic health, and cancer
Centers for Disease Control and Prevention (CDC) data show that over 100 million US adults are obese, PwC noted, while an analysis published in JAMA Cardiology in November determined that 137 million Americans may be eligible for the GLP-1 drug semaglutide (prescribed as Wegovy for weight loss and Ozempic for type 2 diabetes)
During use, adjust doses based on lab trends or symptoms such as IGF-1 overshoot, edema, glucose disturbances, or fatigue
By maintaining these rigorous standards, we ensure that your treatment is safe, potent, and precisely formulated to meet the specific requirements of your personalized protocol